Abbott partners with Intoximeters to bring new drug and alcohol testing

Abbott and Intoximeters have announced an agreement for Intoximeters to market Abbott’s SoToxa Mobile Test System – a handheld oral fluid roadside testing solution that rapidly and reliably detects recent drug use – alongside Intoximeters’ Alco-Sensor brand breath alcohol-testing products.

This agreement will aid law-enforcement agencies in their efforts to reduce the rate of drugged driving, which has become a serious road safety issue. Together, these technologies provide police with a robust set of roadside-testing tools for detection of alcohol on Intoximeters’ products and six drug classes on Abbott’s SoToxa, including amphetamine, benzodiazepines, cannabis (THC), cocaine, methamphetamine, and opiates.

Intoximeters will have exclusive distribution rights for SoToxa in the United States.